MGNX – Macrogenics Inc
MacroGenics, Inc.MGNX
$1.19Name : MacroGenics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $75,077,464.00
EPSttm : -0.88
MacroGenics, Inc.
$1.19
6.30%$0.08Float Short %
9.55
Margin Of Safety %
Put/Call OI Ratio
0.45
EPS Next Q Diff
0.34
EPS Last/This Y
0.44
EPS This/Next Y
-2.03
Price
1.21
Target Price
4.2
Analyst Recom
2.57
Performance Q
-19.59
Relative Volume
8.22
Beta
1.61
Ticker: MGNX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-06-02 | MGNX | 1.39 | 0.88 | 0.00 | 2124 |
| 2025-06-03 | MGNX | 1.515 | 0.88 | 0.00 | 2125 |
| 2025-06-04 | MGNX | 1.495 | 0.87 | 0.00 | 2126 |
| 2025-06-05 | MGNX | 1.445 | 0.86 | 999.99 | 2146 |
| 2025-06-06 | MGNX | 1.765 | 0.87 | 0.00 | 2156 |
| 2025-06-09 | MGNX | 1.64 | 0.86 | 0.00 | 2163 |
| 2025-06-10 | MGNX | 1.79 | 0.68 | 0.03 | 2469 |
| 2025-06-11 | MGNX | 1.715 | 0.15 | 0.03 | 7772 |
| 2025-06-12 | MGNX | 1.565 | 0.15 | 0.01 | 8060 |
| 2025-06-13 | MGNX | 1.525 | 0.14 | 0.11 | 8540 |
| 2025-06-16 | MGNX | 1.51 | 0.14 | 0.00 | 8583 |
| 2025-06-17 | MGNX | 1.37 | 0.14 | 2.13 | 8594 |
| 2025-06-18 | MGNX | 1.374 | 0.14 | 1.45 | 8594 |
| 2025-06-20 | MGNX | 1.315 | 0.14 | 0.00 | 8640 |
| 2025-06-23 | MGNX | 1.315 | 0.43 | 0.10 | 3414 |
| 2025-06-24 | MGNX | 1.35 | 0.42 | 1.40 | 3424 |
| 2025-06-25 | MGNX | 1.32 | 0.43 | 5.00 | 3425 |
| 2025-06-26 | MGNX | 1.27 | 0.45 | 0.05 | 3481 |
| 2025-06-27 | MGNX | 1.21 | 0.45 | 20.00 | 3501 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-06-02 | MGNX | 1.39 | 25.8 | - | -1.82 |
| 2025-06-03 | MGNX | 1.51 | 25.8 | - | -1.82 |
| 2025-06-04 | MGNX | 1.50 | 25.8 | - | -1.82 |
| 2025-06-05 | MGNX | 1.45 | 25.8 | - | -1.82 |
| 2025-06-06 | MGNX | 1.76 | 25.8 | - | -1.82 |
| 2025-06-09 | MGNX | 1.64 | 25.8 | - | -1.82 |
| 2025-06-10 | MGNX | 1.79 | 25.8 | - | -1.82 |
| 2025-06-11 | MGNX | 1.71 | 25.8 | - | -1.82 |
| 2025-06-12 | MGNX | 1.55 | 25.8 | - | -1.82 |
| 2025-06-13 | MGNX | 1.53 | 25.8 | - | -0.63 |
| 2025-06-16 | MGNX | 1.51 | 142.7 | - | -0.63 |
| 2025-06-17 | MGNX | 1.37 | 142.7 | - | -0.63 |
| 2025-06-18 | MGNX | 1.37 | 142.7 | - | -0.63 |
| 2025-06-20 | MGNX | 1.31 | 142.7 | - | -0.63 |
| 2025-06-23 | MGNX | 1.32 | 142.7 | - | -0.63 |
| 2025-06-24 | MGNX | 1.35 | 142.7 | - | -0.63 |
| 2025-06-25 | MGNX | 1.32 | 142.7 | - | -0.63 |
| 2025-06-26 | MGNX | 1.26 | 142.7 | - | -0.63 |
| 2025-06-27 | MGNX | 1.21 | 142.7 | - | -0.63 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-06-02 | MGNX | -0.01 | -5.12 | 10.52 |
| 2025-06-03 | MGNX | -0.01 | -5.12 | 10.52 |
| 2025-06-04 | MGNX | -0.01 | -5.12 | 10.52 |
| 2025-06-05 | MGNX | -0.01 | -5.12 | 10.52 |
| 2025-06-06 | MGNX | -0.01 | -5.12 | 10.52 |
| 2025-06-09 | MGNX | -0.01 | -4.91 | 10.52 |
| 2025-06-11 | MGNX | -0.01 | -4.91 | 10.56 |
| 2025-06-12 | MGNX | -0.01 | -4.91 | 10.56 |
| 2025-06-13 | MGNX | -0.01 | -4.91 | 10.56 |
| 2025-06-16 | MGNX | -0.01 | -4.95 | 10.56 |
| 2025-06-17 | MGNX | -0.01 | -4.95 | 10.56 |
| 2025-06-18 | MGNX | -0.01 | -4.95 | 10.56 |
| 2025-06-19 | MGNX | -0.01 | -4.95 | 10.56 |
| 2025-06-20 | MGNX | -0.01 | -4.95 | 10.56 |
| 2025-06-24 | MGNX | -0.01 | -26.16 | 10.56 |
| 2025-06-25 | MGNX | -0.01 | -26.16 | 10.56 |
| 2025-06-26 | MGNX | -0.01 | -26.16 | 9.55 |
| 2025-06-27 | MGNX | -0.01 | -26.16 | 9.55 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.65
Avg. EPS Est. Current Quarter
0.38
Avg. EPS Est. Next Quarter
-0.31
Insider Transactions
-0.01
Institutional Transactions
-26.16
Beta
1.61
Average Sales Estimate Current Quarter
28
Average Sales Estimate Next Quarter
23
Fair Value
Quality Score
40
Growth Score
39
Sentiment Score
13
Actual DrawDown %
96.7
Max Drawdown 5-Year %
-97
Target Price
4.2
P/E
Forward P/E
PEG
P/S
0.49
P/B
0.95
P/Free Cash Flow
EPS
-0.89
Average EPS Est. Cur. Y
-0.63
EPS Next Y. (Est.)
-2.66
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-36.23
Relative Volume
8.22
Return on Equity vs Sector %
-94.4
Return on Equity vs Industry %
-76.6
EPS 1 7Days Diff
1.2
EPS 1 30Days Diff
2.26
EBIT Estimation
MacroGenics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 341
MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule for the treatment of solid tumors, which is in preclinical trials. It is also developing next generation T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland.
stock quote shares MGNX – Macrogenics Inc Stock Price stock today
news today MGNX – Macrogenics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MGNX – Macrogenics Inc yahoo finance google finance
stock history MGNX – Macrogenics Inc invest stock market
stock prices MGNX premarket after hours
ticker MGNX fair value insiders trading